Functional life-long maintenance of engineered liver tissue in mice following transplantation under the kidney capsule

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 2, 2010, Pages 141-148

  Ohashi, Kazuo ^a   Koyama, Fumikazu ^b   Tatsumi, Kohei ^a,b   Shima, Midori ^b   Park, Frank ^c   Nakajima, Yoshiyuki ^b   Okano, Teruo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Drug metabolism; Hepatocyte transplantation; Liver function; Liver regeneration; Liver tissue engineering; Regenerative medicine

Indexed keywords

CELL ENGINEERING; ENZYME ACTIVITY; HISTOLOGY; MAMMALS; REGENERATIVE MEDICINE; TISSUE REGENERATION;

ANTITRYPSIN; DRUG METABOLISMS; HEPATOCYTE TRANSPLANTATION; HEPATOCYTES; KIDNEY CAPSULES; LIVER FUNCTIONS; LIVER REGENERATION; LIVER TISSUE; LIVER TISSUE ENGINEERING; REGENERATIVE MEDICINE;

TISSUE;

ALPHA 1 ANTITRYPSIN; CYTOCHROME P450; GLYCOGEN; MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BASED GENE THERAPY; CELL ISOLATION; CONTROLLED STUDY; DRUG METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; IMMUNOHISTOCHEMISTRY; KIDNEY CAPSULE; LIVER; LIVER CELL; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL TIME; TISSUE ENGINEERING; TRANSGENIC MOUSE;

EID: 77649201757     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.225     Document Type: Article

References (31)

1. Braet F, Luo D, Spector I, et al. 2001; Endothelial and pit cells. In The Liver: Biology and Pathobiology, 4th edn, Arias IM, Boyer JL, Chisari FV, et al. (eds). Lippincott, Williams & Wilkins: Philadelphia, PA; 437-454.
2. Bumgardner GL, Li J, Heininger M, et al. 1998; In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 65: 47-52.
3. Fahl WE, Michalopoulos G, Sattler GL, et al. 1979; Characteristics of microsomal enzyme controls in primary cultures of rat hepatocytes. Arch Biochem Biophys 192: 61-72.
4. Fausto N. 2001; Liver regeneration. In The Liver: Biology and Pathobiology, 4th edn, Arias IM, Boyer JL, Chisari FV, et al. (eds). Lippincott, Williams & Wilkins: Philadelphia, PA; 591-610.
5. Fisher RA, Strom SC. 2006; Human hepatocyte transplantation: worldwide results. Transplantation 82: 441-449.
6. Fox IJ, Chowdhury JR, Kaufman SS, et al. 1998; Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422-1426.
7. Fox IJ, Schafer DF, Yannam GR. 2006; Finding a home for cell transplants: location, location, location. Am J Transpl 6: 5-6.
8. Gomez-Lechon MJ, Donato MT, Castell JV, et al. 2004; Human hepatocyte in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab 5: 443-462.
9. Griffith JG, Naughton G. 2002; Tissue engineering - current challenges and expanding opportunities. Science 295: 1009-1016.
10. Kohn RR. 1971; Aging of animals: observations and questions. In Principles of Mammalian Aging, KohnRR (ed.). Prentice-Hall: Englewood Cliffs, NJ; 105-137.
11. Kuge H, Ohashi K, Yokoyama T, et al. 2006; Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering. Cell Transpl 15: 1-12.
12. Michalopoulos GK. Liver regeneration. 2007; J Cell Physiol 213: 286-300.
13. Ofosu FA. 2008; Propagation factor IX-producing hepatocytes for haemophilia B therapy. Thromb Haemost 99: 799-800.
14. Ohashi K, Tatsumi M, Tsujiuchi T, et al. 1996; Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a cholchicine-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res 56: 3474-3479.
15. Ohashi K, Marion PL, Nakai H, et al. 2000; Sustained survival of human hepatocytes in mice: a model for in vivo infection with human hepatitis B and hepatitis delta viruses. NatMed 6: 327-331.
16. Ohashi K, Park F, Kay MA. 2001; Hepatocyte transplantation: clinical and experimental application. J MolMed 79: 617-630.
17. Ohashi K, Waugh JM, Dake MD, et al. 2005; Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 41: 132-140.
18. Ohashi K, Kay MA, Yokoyama T, et al. 2005; Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice. Cell Transpl 14: 621-627.
19. Ohashi K, Kay MA, Kuge H, et al. 2005; Heterotopically transplanted hepatocyte survival depends on extracellular matrix components. Transpl Proc 37: 4587-4588.
20. Ohashi K, Yokoyama T, Yamato M, et al. 2007; Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat Med 13: 880-885.
21. Ohashi K. 2008; Liver tissue engineering: the future of liver therapeutics. Hepatol Res 38: S76-87.
22. Sole K. 2006; New device aids bioengineering of hepatic tissues. Nature Clin Prac Gastroenterol Hepatol 3: 183.
23. Stephenne X, Najimi M, Sibille C, et al. 2006; Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130: 1317-1323.
24. Stephenne X, Vosters O, Najimi M, et al. 2007; Tissue factordependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl 13: 599-606.
25. Strain AJ, Neuberger JM. 2002; A bioartificial liver - state of the art. Science 295: 1005-1007.
26. Strom SC, Bruzzone P, Cai H, et al. 2006; Hepatocyte transplantation: clinical experience and potential for future use. Cell Transpl 15: S105-110.
27. TatsumiK, OhashiK, KataokaM, et al. 2008a; Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy for haemophilia B. Thromb Haemost 99: 883-891.
28. Tatsumi K, Ohashi K, ShimaM, et al. 2008b; Therapeutic effects of hepatocyte transplantation on hemophilia B. Transplantation 86: 167-170.
29. Waxman DJ, Azaroff L. 2006; Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281(pt 3): 577-592.
30. Yokoyama T, Ohashi K, Kuge H, et al. 2006; In vivo engineering of metabolically active hepatic tissues in a neovascularized subcutaneous cavity. Am J Transpl 6: 50-59.
31. Zacharova LY, Gulyaeva LF, Lyakhovich VV, et al. 2003; Cytochrome P4501A1 and 1A2 gene expression in the liver of 3-methylcholanthrene- and o-aminoazotoluene-treated mice: a comparison between PAH-responsive and PAH-nonresponsive strains. Toxicol Sci 73: 108-111.